About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Waptm1(cre)Arge
targeted mutation 1, Argiris Efstratiadis
MGI:2177210
Summary 16 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Waptm1(cre)Arge/Waptm1(cre)Arge involves: 129S1/Sv * C57BL/6J MGI:3038955
cn2
Eef1a1tm1(Kras*)Arge/Eef1a1+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv MGI:3837707
cn3
Eef1a1tm1(Kras*)Arge/Eef1a1+
Igf1rtm2Arge/Igf1rtm2Arge
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv MGI:3837711
cn4
Actbtm1(PyVT)Arge/Actb+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv MGI:3032632
cn5
Eef1a1tm1(Kras*)Arge/Eef1a1+
Igf1rtm2Arge/Igf1r+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv MGI:3837708
cn6
Brca1tm2.1Cxd/Brca1tm3.1Rjbr
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 MGI:5494461
cn7
Brca1tm2.1Cxd/Brca1tm2Rjbr
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 MGI:5494458
cn8
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 MGI:5494460
cn9
Brca1tm2.1Cxd/Brca1tm3.1Rjbr
Waptm1(cre)Arge/Wap+
involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 MGI:5494459
cn10
Brca2tm2Arge/Brca2tm2Arge
Waptm1(cre)Arge/Waptm1(cre)Arge
involves: 129S1/Sv * C57BL/6 MGI:2177239
cn11
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
involves: 129S1/Sv * C57BL/6J MGI:3805033
cn12
Bard1tm1Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
involves: 129S1/Sv * C57BL/6J MGI:3805024
cn13
Brca1tm1Arge/Brca1tm1Thl
Waptm1(cre)Arge/0
involves: 129S/SvEv * 129S1/Sv * C57BL/6J MGI:3805032
cn14
Brca2tm1Arge/Brca2tm2Arge
Waptm1(cre)Arge/Wap+
involves: 129S/SvEv * C57BL/6 MGI:2177237
cn15
Bard1tm2Thl/Bard1tm2Thl
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
involves: 129/Sv * 129S1/Sv * C57BL/6J MGI:3805035
cn16
Bard1tm2Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
involves: 129/Sv * 129S1/Sv * C57BL/6J MGI:3805029


Genotype
MGI:3038955
hm1
Allelic
Composition
Waptm1(cre)Arge/Waptm1(cre)Arge
Genetic
Background
involves: 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no overt phenotype; females do not appear to have a defect in maternal milk production or quality




Genotype
MGI:3837707
cn2
Allelic
Composition
Eef1a1tm1(Kras*)Arge/Eef1a1+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eef1a1tm1(Kras*)Arge mutation (0 available); any Eef1a1 mutation (60 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Histology and immunophenotyping of mammary carcinomas in Eef1a1tm1(Kras*)Arge/Eef1a1+ Waptm1(cre)Arge/Wap+ mice

mortality/aging
• median tumor-free survival of lactating female mice is 9 days from the first parturition

neoplasm
• within 2 days to 2 months of first delivery, lactating females develop palpable multifocal, fully invasive tumors of the mammary gland unlike wild-type mice
• median tumor-free survival of lactating female mice is 9 days from the first parturition
• lactating female mice develop adenocarcinomas, and pale, squamous, and spindle cell carcinomas
• however, treatment with picropodophyllin decreases tumor mass

endocrine/exocrine glands
• within 2 days to 2 months of first delivery, lactating females develop palpable multifocal, fully invasive tumors of the mammary gland unlike wild-type mice
• median tumor-free survival of lactating female mice is 9 days from the first parturition
• lactating female mice develop adenocarcinomas, and pale, squamous, and spindle cell carcinomas
• however, treatment with picropodophyllin decreases tumor mass

integument
• within 2 days to 2 months of first delivery, lactating females develop palpable multifocal, fully invasive tumors of the mammary gland unlike wild-type mice
• median tumor-free survival of lactating female mice is 9 days from the first parturition
• lactating female mice develop adenocarcinomas, and pale, squamous, and spindle cell carcinomas
• however, treatment with picropodophyllin decreases tumor mass

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:146290




Genotype
MGI:3837711
cn3
Allelic
Composition
Eef1a1tm1(Kras*)Arge/Eef1a1+
Igf1rtm2Arge/Igf1rtm2Arge
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eef1a1tm1(Kras*)Arge mutation (0 available); any Eef1a1 mutation (60 available)
Igf1rtm2Arge mutation (1 available); any Igf1r mutation (86 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median tumor free survival of lactating females is 101 days from the first parturition

neoplasm
• female mice develop mammary gland tumors after 3 pregnancies with an 11-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 101 days from the first parturition

endocrine/exocrine glands
• female mice develop mammary gland tumors after 3 pregnancies with an 11-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 101 days from the first parturition

integument
• female mice develop mammary gland tumors after 3 pregnancies with an 11-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 101 days from the first parturition




Genotype
MGI:3032632
cn4
Allelic
Composition
Actbtm1(PyVT)Arge/Actb+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Actbtm1(PyVT)Arge mutation (0 available); any Actb mutation (51 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• premature death

neoplasm

cardiovascular system
• exhibited by 70% of females (mostly virgins, indicating that this phenotype is associated with cre-independent excision of the floxed neomycin cassette)

muscle
• exhibited by 70% of females (mostly virgins, indicating that this phenotype is associated with cre-independent excision of the floxed neomycin cassette)

integument

endocrine/exocrine glands




Genotype
MGI:3837708
cn5
Allelic
Composition
Eef1a1tm1(Kras*)Arge/Eef1a1+
Igf1rtm2Arge/Igf1r+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eef1a1tm1(Kras*)Arge mutation (0 available); any Eef1a1 mutation (60 available)
Igf1rtm2Arge mutation (1 available); any Igf1r mutation (86 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median tumor free survival of lactating females is 43 days from the first parturition

neoplasm
• female mice develop mammary gland tumors with a 5-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 43 days from the first parturition

endocrine/exocrine glands
• female mice develop mammary gland tumors with a 5-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 43 days from the first parturition

integument
• female mice develop mammary gland tumors with a 5-fold increase in latency compared to in Eef1a1tm1(Kras*)Arge Waptm1(cre)Arge heterozygotes
• median tumor free survival of lactating females is 43 days from the first parturition




Genotype
MGI:5494461
cn6
Allelic
Composition
Brca1tm2.1Cxd/Brca1tm3.1Rjbr
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2.1Cxd mutation (1 available); any Brca1 mutation (113 available)
Brca1tm3.1Rjbr mutation (1 available); any Brca1 mutation (113 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (232 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• compared with Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm3Tyj/Trp53tm3Tyj Waptm1(cre)Arge/Waptm1(cre)Arge




Genotype
MGI:5494458
cn7
Allelic
Composition
Brca1tm2.1Cxd/Brca1tm2Rjbr
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2.1Cxd mutation (1 available); any Brca1 mutation (113 available)
Brca1tm2Rjbr mutation (1 available); any Brca1 mutation (113 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (232 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 308 days compared with 380 days in Trp53tm3Tyj Waptm1(cre)Arge double heterozygotes
• however, latency is similar to in Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm3Tyj/Trp53+ Waptm1(cre)Arge/Wap+




Genotype
MGI:5494460
cn8
Allelic
Composition
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm3Tyj/Trp53+
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJae * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2.1Cxd mutation (1 available); any Brca1 mutation (113 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (232 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 308 days compared with 380 days in Trp53tm3Tyj Waptm1(cre)Arge double heterozygotes




Genotype
MGI:5494459
cn9
Allelic
Composition
Brca1tm2.1Cxd/Brca1tm3.1Rjbr
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2.1Cxd mutation (1 available); any Brca1 mutation (113 available)
Brca1tm3.1Rjbr mutation (1 available); any Brca1 mutation (113 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• unlike in mice with Brca1tm2.1Cxd/Brca1tm2.1Cxd Waptm1(cre)Arge/Wap+, mice remain tumor free over a 24-month observation period




Genotype
MGI:2177239
cn10
Allelic
Composition
Brca2tm2Arge/Brca2tm2Arge
Waptm1(cre)Arge/Waptm1(cre)Arge
Genetic
Background
involves: 129S1/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm2Arge mutation (0 available); any Brca2 mutation (132 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

endocrine/exocrine glands
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

integument
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:70564




Genotype
MGI:3805033
cn11
Allelic
Composition
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
Genetic
Background
involves: 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Thl mutation (1 available); any Brca1 mutation (113 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

integument
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

endocrine/exocrine glands
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:134977




Genotype
MGI:3805024
cn12
Allelic
Composition
Bard1tm1Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
Genetic
Background
involves: 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bard1tm1Thl mutation (0 available); any Bard1 mutation (54 available)
Bard1tm2Thl mutation (0 available); any Bard1 mutation (54 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

integument
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

endocrine/exocrine glands
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:134977




Genotype
MGI:3805032
cn13
Allelic
Composition
Brca1tm1Arge/Brca1tm1Thl
Waptm1(cre)Arge/0
Genetic
Background
involves: 129S/SvEv * 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Arge mutation (0 available); any Brca1 mutation (113 available)
Brca1tm1Thl mutation (1 available); any Brca1 mutation (113 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

integument
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

endocrine/exocrine glands
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 512 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:134977




Genotype
MGI:2177237
cn14
Allelic
Composition
Brca2tm1Arge/Brca2tm2Arge
Waptm1(cre)Arge/Wap+
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Arge mutation (0 available); any Brca2 mutation (132 available)
Brca2tm2Arge mutation (0 available); any Brca2 mutation (132 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

endocrine/exocrine glands
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

integument
• mammary tumors occur after long latency of at least 13 months of age
• T50 for tumor-free survival is approximately 17 months of age
• at the end of the 20 month observation period, 20 of 26 animals developed mammary tumors; control animals developed none
• tumor pathology corresponded to two characteristic types, solid carcinoma and adenoacanthoma, with a mixture of the two types frequently appearing in the same tumor mass

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:70564




Genotype
MGI:3805035
cn15
Allelic
Composition
Bard1tm2Thl/Bard1tm2Thl
Brca1tm1Thl/Brca1tm1Thl
Waptm1(cre)Arge/0
Genetic
Background
involves: 129/Sv * 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bard1tm2Thl mutation (0 available); any Bard1 mutation (54 available)
Brca1tm1Thl mutation (1 available); any Brca1 mutation (113 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 473 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

integument
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 473 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

endocrine/exocrine glands
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 473 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:134977




Genotype
MGI:3805029
cn16
Allelic
Composition
Bard1tm2Thl/Bard1tm2Thl
Waptm1(cre)Arge/0
Genetic
Background
involves: 129/Sv * 129S1/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bard1tm2Thl mutation (0 available); any Bard1 mutation (54 available)
Waptm1(cre)Arge mutation (0 available); any Wap mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

endocrine/exocrine glands
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

integument
• almost all female mice who have been pregnant at least once develop mammary tumors with a mean tumor free latency of 465 days
• majority of tumors are solid, do not express the estrogen receptor but are CK14 positive
• the majority of the tumors are Dunn type B adenocarcinomas with a medullary growth pattern that display variable necrosis and lack peripheral lymphocytic infiltrate
• carnicomas contain pleomorphic cells with numerous mitotic figures such as lagging chromosomes
• neoplasms often invade in a broad front and push towards the underlying pectoral muscle
• a small minority of tumors have sqaumous characteristics
• pre-cancerous neoplasia are also evident throughout the mammary gland

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:134977





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/21/2024
MGI 6.23
The Jackson Laboratory